Results 171 to 180 of about 77,609 (253)

Treatment history: Factors that affect the outcome of hepatitis c virus treatment with interferon-alpha 2a/b and ribavirin

, 2018
Tijana Spasojević, Nevenka Bujandrić, Miloš Vujanović   +2 more
openalex   +2 more sources

Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks [PDF]

, 2011
Christoph Sarrazin, Susanne Schwendy, Bernd Möller, Nektarios Dikopoulos, Peter Buggisch, Jens Encke, G Teuber, Tobias Goeser, Robert Thimme, Hartwig Klinker, Wulf O. Boecher, Ewert Schulte‐Frohlinde, R Prinzing, Eva Herrmann, Stefan Zeuzem, Thomas Berg   +15 more
openalex   +1 more source

Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium. [PDF]

Liver Int
Buchardt L, Thi VLD, Johne R, Ziersch M, Harms D, Hofmann J, Dinkelborg K, Klöhn M, Choi M, Kurreck J, Wedemeyer H, Todt D.   +11 more
europepmc   +1 more source

Real Data on Effect of a Combination of Nitazoxanide, Ribavirin and Ivermectin Plus Zinc Supplement on the Clearance of COVID-19 Versus Remdesivir or Favipiravir in Hospitalized COVID Cases [PDF]

Hatem Elalfy, Tarek Besheer, Mahmoud Abdel‐Aziz Soliman, Ahmed El‐Mesery, Mohamed Alegezy, Mohamed Elegezy, Abdel‐Hady El‐Gilany, Hosam Zaghloul, Mustafa Neamatallah, Nermin Y. Abo El Kheir, Maii Saad, Doaa Khedr, Adel El‐Badrawy, Ahmed Ezzat Helal, Mahmoud El‐Bendary, Tamer Elhadidy   +15 more
openalex   +1 more source

Acute Hepatic Failure in Crimean-Congo Hemorrhagic Fever: A Case Report. [PDF]

Clin Case Rep
Shahatta AA, Al-Badri SG, Naeem K, Hamid AK, Al-Fatlawi N, Al-Shammari AS, Sayed SBH, Abbas AH, Shlaka AA.   +8 more
europepmc   +1 more source

Discovery of bioactive inhibitors targeting onion yellow dwarf virus coat protein based on molecular docking and simulation. [PDF]

BMC Plant Biol
Irfan A, Awan MF, Naz Q, Sarwar MF, Mujwar S, Mubeen I, Obaidur Rab S.   +6 more
europepmc   +1 more source

Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon α-2a and Ribavirin for Chronic Hepatitis C

, 2015
Chetan Rathi, Nirav Pipaliya, Dhaval Choksi, Pathik Parikh, Meghraj Ingle, Prabha Sawant   +5 more
openalex   +1 more source

Ribavirin [PDF]

, 2020
openaire   +1 more source

New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, and <i>in vitro</i> experiments. [PDF]

Microbiol Spectr
Huang L, Halihaman B, Han Y, Zhou J, Liu C, Bai H, Ding X.   +6 more
europepmc   +1 more source

ORIGINAL PAPER
Combined interferon-alpha-2b and ribavirin therapy in patients with recurring chronic hepatitis C (genotype 1) following liver transplantation in Hungary

, 2005
Gabriella Lengyel, Laśzló Kob́ori, Imre Fehérvári, Balázs Nemes, Dénes Görög, Attila Patonai, Enikő Sárváry, Marina Varga, Krisztina Hagymási, Ferenc Perner, János Fehér, Zsolt Tulassay   +11 more
openalex   +1 more source